Search results
In the wake of Denali Therapeutics Inc.'s (NASDAQ:DNLI) latest US$402m market cap drop,...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Given the large stake in the stock by institutions, Denali Therapeutics' stock price...
After losing 39% in the past year, Denali Therapeutics Inc. (NASDAQ:DNLI) institutional owners must...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Given the large stake in the stock by institutions, Denali Therapeutics' stock price...
The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically
Simply Wall St. via Yahoo Finance· 6 days agoThe latest analyst coverage could presage a bad day for Denali Therapeutics Inc. (NASDAQ:DNLI), with...
Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses...
Simply Wall St. via Yahoo Finance· 2 months agoDenali Therapeutics Inc. (NASDAQ:DNLI) shareholders should be happy to see the share price up 18% in...
Analysts' Revenue Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Are Surging Higher
Simply Wall St. via Yahoo Finance· 2 years agoDenali Therapeutics Inc. (NASDAQ:DNLI) shareholders will have a reason to smile today, with the...
Shareholders in Denali Therapeutics (NASDAQ:DNLI) are in the red if they invested three years ago
Simply Wall St. via Yahoo Finance· 7 months agoIn order to justify the effort of selecting individual stocks, it's worth striving to beat the...
Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 40% Undervaluation?
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Denali Therapeutics' estimated fair value is US$43.39 based on 2 Stage Free Cash Flow...
Denali Therapeutics (NASDAQ:DNLI) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 12 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
Pinning Down Denali Therapeutics Inc.'s (NASDAQ:DNLI) P/S Is Difficult Right Now
Simply Wall St. via Yahoo Finance· 9 months agoThere wouldn't be many who think Denali Therapeutics Inc.'s (NASDAQ:DNLI) price-to-sales (or "P/S")...
We Think Denali Therapeutics (NASDAQ:DNLI) Can Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 2 years agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...